Siamab Therapeutics' Incubator/Accelerator Round

Siamab Therapeutics raised a round of funding on March 01, 2015. Investors include JLabs.

Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of the…

Articles about Siamab Therapeutics' Incubator/Accelerator Round: